These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9373785)

  • 21. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A; Jackson DM; Eriksson A; Mohell N
    Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
    Seeman P; Van Tol HH
    Eur J Pharmacol; 1995 Oct; 291(2):59-66. PubMed ID: 8566176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
    Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA; Evans DL; Stratman NC; Figur LM
    Eur J Pharmacol; 1993 Jun; 236(3):483-6. PubMed ID: 8102973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
    Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
    Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioreceptor binding profile of the atypical antipsychotic olanzapine.
    Bymaster FP; Calligaro DO; Falcone JF; Marsh RD; Moore NA; Tye NC; Seeman P; Wong DT
    Neuropsychopharmacology; 1996 Feb; 14(2):87-96. PubMed ID: 8822531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
    Coldwell MC; Boyfield I; Brown AM; Stemp G; Middlemiss DN
    Br J Pharmacol; 1999 Jul; 127(5):1135-44. PubMed ID: 10455259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
    Seeman P; Corbett R; Van Tol HH
    Adv Pharmacol; 1998; 42():478-82. PubMed ID: 9327943
    [No Abstract]   [Full Text] [Related]  

  • 36. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
    Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
    Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
    J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine: selective labeling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile.
    Glatt CE; Snowman AM; Sibley DR; Snyder SH
    Mol Med; 1995 May; 1(4):398-406. PubMed ID: 8521297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.